We are live on ! Find out more
KAM

Krensavage Asset Management Portfolio holdings

AUM $256M
1-Year Est. Return 69.63%
This Fund
S&P 500
This Quarter Est. Return
+9.24%
1 Year Est. Return
+69.63%
3 Year Est. Return
+113.28%
5 Year Est. Return
+196.5%
10 Year Est. Return
+463.27%
AUM
$313M
AUM Growth
+$37.2M
Cap. Flow
+$18.5M
Cap. Flow %
5.89%
Top 10 Hldgs %
73.91%
Holding
24
New
1
Increased
20
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
+$5.37M
2
ENTA icon
Enanta Pharmaceuticals
ENTA
+$4.83M
3
DSCI
Derma Sciences, Inc. Common Stock (DE)
DSCI
+$4.28M
4
CNMD icon
CONMED
CNMD
+$2.36M
5
IPXL
Impax Laboratories, Inc.
IPXL
+$2.17M

Top Sells

Rank Stock Value
1
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$8.74M
2
FURX
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
+$1.42M
3
INVA icon
Innoviva
INVA
+$1.26M

Sector Composition

Rank Sector Weight
1 Healthcare 72.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$25.8B
$33.6M 10.72%
214,456
+14,883
+7% +$2.17M
ENTA icon
2
Enanta Pharmaceuticals
ENTA
$366M
$29M 9.25%
878,446
+148,138
+20% +$4.83M
BXLT
3
DELISTED
BAXALTA INC COM STK (DE)
BXLT
$28.8M 9.19%
738,365
+16,565
+2% +$577K
TEVA icon
4
Teva Pharmaceuticals
TEVA
$40.8B
$25.8M 8.22%
392,697
+19,635
+5% +$1.21M
OFIX icon
5
Orthofix Medical
OFIX
$477M
$25.1M 8.01%
640,176
+29,929
+5% +$1.12M
IPXL
6
DELISTED
Impax Laboratories, Inc.
IPXL
$25M 7.98%
585,170
+54,295
+10% +$2.17M
AVNS
7
DELISTED
Avanos Medical
AVNS
$18.9M 6.02%
564,952
+29,009
+5% +$902K
AMGN icon
8
Amgen
AMGN
$208B
$17.5M 5.58%
107,763
+4,227
+4% +$664K
CNMD icon
9
CONMED
CNMD
$1.39B
$14.5M 4.62%
329,011
+54,483
+20% +$2.36M
MRK icon
10
Merck
MRK
$322B
$13.5M 4.3%
267,286
+5,807
+2% +$293K
SRGA
11
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$12.2M 3.9%
102,564
+41,608
+68% +$5.37M
SCMP
12
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$9.61M 3.07%
555,652
+27,477
+5% +$493K
AGN
13
DELISTED
Allergan plc
AGN
$8.25M 2.63%
26,394
+2,154
+9% +$641K
ASRT
14
DELISTED
Assertio
ASRT
$8.13M 2.6%
7,479
+1,223
+20% +$1.38M
IVC
15
DELISTED
Invacare Corporation
IVC
$7.36M 2.35%
423,280
+20,898
+5% +$377K
SPPI
16
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$6.62M 2.11%
1,097,335
+18,833
+2% +$108K
VXRT
17
DELISTED
Vaxart
VXRT
$5.09M 1.63%
238,658
+4,969
+2% +$109K
DSCI
18
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$4.12M 1.31%
+901,834
New +$4.28M
JNP
19
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$2.97M 0.95%
288,326
+8,609
+3% +$99.8K
STRR
20
DELISTED
Star Equity Holdings
STRR
$2.79M 0.89%
9,620
+466
+5% +$128K
HRC
21
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$1.66M 0.53%
34,605
-171,108
-83% -$8.74M
INVA icon
22
Innoviva
INVA
$1.55B
– –
-176,108
Closed -$1.26M
FURX
23
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
– –
-145,544
Closed -$1.42M

Similar funds

CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
2
2Xideas Kusnacht, Switzerland $255M AUM 0.46% 1-Year Est. Return
CIM
Caldwell Investment Management Toronto, Ontario, Canada $255M AUM 36.87% 1-Year Est. Return
JFG
Juno Financial Group Richmond, Virginia $255M AUM
PIP
Palisades Investment Partners Santa Monica, California $255M AUM 50.52% 1-Year Est. Return
LRIC
Long Road Investment Counsel Kalamazoo, Michigan $255M AUM 12.85% 1-Year Est. Return
GAMC
Garner Asset Management Corp Plano, Texas $255M AUM 22.93% 1-Year Est. Return
TIA
Tiemann Investment Advisors Menlo Park, California $255M AUM 21.35% 1-Year Est. Return

Krensavage Asset Management's Q4 2015 Portfolio in Review

As of Q4 2015, Krensavage Asset Management held 24 positions worth $313M, up 13% from $276M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Krensavage Asset Management deployed $18.5M of net new capital in Q4 2015, opening 1 new position and adding to 20 existing holdings. Its largest new stake was Derma Sciences, Inc. Common Stock (DE): 901,834 shares worth $4.12M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, up from 69% a quarter earlier.

On the sell side, the largest reduction was HILL-ROM HOLDINGS, INC., an estimated $8.74M trimmed.

  • Krensavage Asset Management's largest Q4 2015 buy was Derma Sciences, Inc. Common Stock (DE): 901,834 shares worth $4.12M.
  • Krensavage Asset Management added most to Surgalign Holdings, Inc. Common Stock in Q4 2015, an estimated $5.37M increase.
  • Krensavage Asset Management's biggest Q4 2015 reduction was HILL-ROM HOLDINGS, INC., cutting an estimated $8.74M.
  • Krensavage Asset Management fully exited FURIEX PHARMACEUTICALS INC COM STK (DE) in Q4 2015, selling an estimated $1.42M.
  • Krensavage Asset Management's ten largest holdings make up 74% of its $313M portfolio in Q4 2015.
  • Krensavage Asset Management opened 1 new position and closed 2 in Q4 2015.
  • Krensavage Asset Management's portfolio value rose 13% quarter-over-quarter to $313M.

Based on Krensavage Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.